Dublin, Oct. 09, 2026 (GLOBE NEWSWIRE) -- "NGS Informatics and Clinical Genomics Market: Focus on Offering, Technology, Application, End User, and Region - Analysis and Forecast, 2026-2036" has been ...
Technological innovation stands as a significant driver propelling the next-generation sequencing (NGS) market growth, with continuous advancements in sequencing platforms, such as whole genome ...
Machine Learning Model for Predicting Severe Adverse Events in Oncology Patients Using the US Food and Drug Administration Adverse Event Reporting System ClinBioNGS is a modular, fully containerized ...
A group of scientists from the US Food and Drug Administration's (FDA) Division of Bioinformatics and Biostatistics have reviewed the algorithms used to align the data generated by next-generation ...
insights from industryChris Forsdyke, Martin LarkeFrancesca Manni, Chelsea PratthVIVO In this interview, Meredith Landry (Managing Editor, Citeline) speaks with Chris Forsdyke (Head of Laboratory ...
Oncology-led NGS adoption, faster automated workflows, companion diagnostics and strategic partnerships are expanding precision medicine across Japan.Dublin, Oct. 02, 2026 (GLOBE NEWSWIRE) -- "Japan ...
The US Food and Drug Administration (FDA) on Thursday published a technical specifications document to help sponsors submit next generation nucleotide sequence analysis procedures and data in support ...
TELO-MRD is a type of liquid-biopsy applied to finding Minimal Residual Disease (MRD) in samples of peripheral blood. It combines enumeration of circulating tumor cells ("CTCs"), specifically ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results